| 1 |
Chemically induced models of Parkinson's disease |
|
|
| Thilaga Thirugnanam, Kirankumar Santhakumar |
|
| Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2022; 252: 109213 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Application of neurotoxin- and pesticide-induced animal models of Parkinson’s disease in the evaluation of new drug delivery systems |
|
|
| Yaquelyn Casanova, Sofia Negro, Emilia Barcia |
|
| Acta Pharmaceutica. 2022; 72(1): 35 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson’s Disease |
|
|
| Gleyce Fonseca Cabral, Ana Paula Schaan, Giovanna C. Cavalcante, Camille Sena-dos-Santos, Tatiane Piedade de Souza, Natacha M. Souza Port’s, Jhully Azevedo dos Santos Pinheiro, Ândrea Ribeiro-dos-Santos, Amanda F. Vidal |
|
| International Journal of Molecular Sciences. 2021; 22(18): 9839 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases |
|
|
| Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo, Mariarosa Anna Beatrice Melone |
|
| Pharmaceutics. 2021; 13(11): 1897 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases |
|
|
| Dejan Aleksic, Srdan Stefanovic, Miloš Milosavljevic, Jovana Milosavljevic, Slobodan Jankovic |
|
| Hospital Pharmacology - International Multidisciplinary Journal. 2021; 8(3): 1099 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
The Correlation Between Parkinson’s Disease and Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review |
|
|
| Niki Shrestha, Rose Anne M Abe, Anum Masroor, Arseni Khorochkov, Jose Prieto, Karan B Singh, Maduka C Nnadozie, Muhammad Abdal, Lubna Mohammed |
|
| Cureus. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Title of the manuscript: Mechanistic insights into chalcone butein-induced inhibition of a-synuclein fibrillation: Biophysical and insilico studies |
|
|
| Tinku, Harshad Paithankar, Ankita R. Rane, Ramakrishna V. Hosur, Sinjan Choudhary |
|
| Journal of Molecular Liquids. 2021; 334: 116105 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Mutational Impact on “in-Between-Ring” (IBR) Domain of PARKIN on Protein Stability and Function |
|
|
| Sima Biswas, Angshuman Bagchi |
|
| Applied Biochemistry and Biotechnology. 2021; 193(6): 1603 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Recent Progress in Non-motor Features of Parkinson’s Disease with a Focus on Circadian Rhythm Dysregulation |
|
|
| Yufei Liu, Long Niu, Xinyao Liu, Cheng Cheng, Weidong Le |
|
| Neuroscience Bulletin. 2021; 37(7): 1010 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Automatic and non-invasive Parkinson’s disease diagnosis and severity rating using LSTM network |
|
|
| Balaji E., Brindha D., Vinodh Kumar Elumalai, Vikrama R. |
|
| Applied Soft Computing. 2021; 108: 107463 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Therapeutic Regime to Ameliorate Quality of Life in Patients with Parkinson’s Disease |
|
|
| Nidhi Sharma, Manpreet Kaur, Anju Goyat, Priyanka Sharma, Adarsh Kumar Srivastav, B. K. Agrawal |
|
| Physical & Occupational Therapy In Geriatrics. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Effects of domotics on cognitive, social and personal functioning in patients with Parkinson’s disease: A pilot study |
|
|
| Desiree Latella, Maria Grazia Maggio, Giuseppa Maresca, Adriana Andaloro, Smeralda Anchesi, Valentina Pajno, Rosaria De Luca, Giuseppe Di Lorenzo, Alfredo Manuli, Rocco Salvatore Calabrò |
|
| Assistive Technology. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy |
|
|
| Rongbo Zhang, Jing Li, You Wu, Shunli Liang, Linsheng Xu |
|
| Genetic Testing and Molecular Biomarkers. 2021; 25(1): 20 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Neuroprotective effects of oleuropein: Recent developments and contemporary research |
|
|
| Masood Sadiq Butt, Urwa Tariq, Iahtisham-Ul-Haq, Ambreen Naz, Muhammad Rizwan |
|
| Journal of Food Biochemistry. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
The Positive Role and Mechanism of Herbal Medicine in Parkinson’s Disease |
|
|
| Rong Yin, Jie Xue, Yanfeng Tan, Chuantao Fang, Chunchun Hu, Qian Yang, Xinyu Mei, Dashi Qi, Silvana Hrelia |
|
| Oxidative Medicine and Cellular Longevity. 2021; 2021: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Cross-talks among GBA mutations, glucocerebrosidase, and a-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review |
|
|
| Tapan Behl, Gagandeep Kaur, Ovidiu Fratila, Camelia Buhas, Claudia Teodora Judea-Pusta, Nicoleta Negrut, Cristiana Bustea, Simona Bungau |
|
| Translational Neurodegeneration. 2021; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
The impact of clinical scales in Parkinson’s disease: a systematic review |
|
|
| Nikita Aggarwal, Barjinder Singh Saini, Savita Gupta |
|
| The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2021; 57(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway |
|
|
| ZhengHu Xu, Dongfeng Yang, Xiaojing Huang, Huai Huang |
|
| Frontiers in Neuroscience. 2021; 15 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Local Translation in Nervous System Pathologies |
|
|
| María Gamarra, Aida de la Cruz, Maite Blanco-Urrejola, Jimena Baleriola |
|
| Frontiers in Integrative Neuroscience. 2021; 15 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
The Histaminergic System in Neuropsychiatric Disorders |
|
|
| Li Cheng, Jiaying Liu, Zhong Chen |
|
| Biomolecules. 2021; 11(9): 1345 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions |
|
|
| Tapan Behl, Gagandeep Kaur, Simona Bungau, Rishabh Jhanji, Arun Kumar, Vineet Mehta, Gokhan Zengin, Roxana Brata, Syed Shams ul Hassan, Ovidiu Fratila |
|
| International Journal of Molecular Sciences. 2020; 21(17): 6235 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Neuroprotective Activity of Protocatechuic Acid (3,4-Dihydroxybenzoic Acid) to Treat Parkinson’s Disease |
|
|
| Jagatheesh Kaliaperumal, Satguru Dulari, Pandurangan A. , Mahendra Singh Rathore, Amit Mittal, Md. Shamshir Alam |
|
| Journal of Evolution of Medical and Dental Sciences. 2020; 9(34): 2466 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Orally Administered Nanotherapeutics For Parkinson’s Disease: An Old Delivery System Yet More Acceptable |
|
|
| Nidhi Aggarwal, Zufika Qamar, Saleha Rehman, Sanjula Baboota, Javed Ali |
|
| Current Pharmaceutical Design. 2020; 26(19): 2280 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease |
|
|
| Gagandeep Kaur, Tapan Behl, Simona Bungau, Arun Kumar, Md. Sahab Uddin, Vineet Mehta, Gokhan Zengin, Bijo Mathew, Muhammad Ajmal Shah, Sandeep Arora |
|
| Current Neuropharmacology. 2020; 19(2): 233 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
The potential role of metformin in the treatment of Parkinson's disease |
|
|
| Mengnan Lu, Huangtao Chen, Fayi Nie, Xinyi Wei, Zhiwei Tao, Jie Ma |
|
| Journal of Bio-X Research. 2020; 3(1): 27 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Curcumin and neurological diseases |
|
|
| Raffaella Adami, Daniele Bottai |
|
| Nutritional Neuroscience. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin |
|
|
| Chen-hong Guo, Ting Cao, Long-tai Zheng, John L Waddington, Xue-chu Zhen |
|
| Acta Pharmacologica Sinica. 2020; 41(4): 499 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population |
|
|
| Vinod Metta, Rupam Borgohain, Prashanth L Kukkle, Rukmini Mridula, Pankaj Agarwal, Asha Kishore, Vinay Goyal, Ray Chaudhuri |
|
| Annals of Movement Disorders. 2020; 3(3): 145 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Natural Approaches for Neurological Disorders—The Neuroprotective Potential of Codium tomentosum |
|
|
| Joana Silva, Alice Martins, Celso Alves, Susete Pinteus, Helena Gaspar, Amparo Alfonso, Rui Pedrosa |
|
| Molecules. 2020; 25(22): 5478 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Nörodejeneratif Hastalik Arastirmalarinda Drosophila melanogaster Modeli |
|
|
| Cem HAZIR, Gamze BORA, Hayat Erdem YURTER |
|
| Uludag Üniversitesi Tip Fakültesi Dergisi. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease |
|
|
| Siyan Zhang, Kai Tao, Jia Wang, Yunyou Duan, Bao Wang, Xi Liu |
|
| Frontiers in Cellular Neuroscience. 2020; 14 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
